Stock info Stericycle | Filter  Basic-Info

Stericycle

Past year was a negative year for Stericycle investors

Over the period from December 2015 till December 2016 the stock lost around 34 percent. Over the period 2011-2016 the stock lost a modest -1,31 percent. Stericycle's revenues between 2011 and 2015 were quite unstable and moved between 1,91 billion dollars and 2,99 billion dollars. During 2011 and 2015 Stericycle's net results were very volatile and fluctuated between 237,34 million dollars and 268,01 million dollars.

Stericycle has it' headquarter based in Lake Forest. The company mostly operates in the pharmaceutical sector. Charles A. Alutto is the company' CEO. Stericycle' CFO is Daniel V. Ginnetti. The period from 2006 till the end of 2016 the international sector gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

Over the past 5 years the American company paid out dividends.

Stericycle financed with a quite low debt position

At the end of 2015 the American company's balance sheet was worth 7,08 billion dollars. Last year the total debt of the company was 4,35 billion dollars. This equals around 61,43 percent of the total balance sheet. Last year the pharmaceutical company's price/earnings-ratio (PE) was around 30. So the investors valued the stock at 30 times 2015' earnings per share. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a growth stock.

At the end of 2015 the American company's market capitalization equaled around 10,03 billion dollars. At the end of 2015 the American company had around 84,85 million stocks listed on the stock exchange(s).

At this page you find all Stericycle's financial reports. More information about Stericycle can be found it's website. .